Interestingly recent studies also demonstrate a specific role of S100A9 in PD, as S100A9 is elevated and co-localizes with alpha-synuclein in PD brains ex vivo, and induces alpha-synuclein aggregation in vitro (Horvath et al., 2018). Here, S100A9 is linked to Parkinson disease.